김욱 (아주대학교)님 | 한빛사연구자 > 한빛사

아주대학교

최종업데이트 2025.09.02.

Discovery of ETI41 and ETI60: novel selective endosomal Toll-like receptor inhibitors for the treatment of autoimmune diseases
- Exp. Mol. Med., Sep 01 2025, | https://doi.org/10.1038/s12276-025-01526-w
- 2025-09
- 의약학
- 한빛사논문
Self-assembled hyaluronic acid nanoparticles for the topical treatment of inflammatory skin diseases: Beyond drug carriers
- J. Control. Release, Volume 366, February 2024, Pages 114-127 | https://doi.org/10.1016/j.jconrel.2023.12.026
- 2024-02
- 의약학
- 한빛사논문
Hyaluronic Acid Nanoparticles as a Topical Agent for Treating Psoriasis
- ACS Nano, Publication Date:November 14, 2022 | https://doi.org/10.1021/acsnano.2c07843
- 2022-11
- 의약학
- 한빛사논문
Self-Assembled Hyaluronic Acid Nanoparticles for Osteoarthritis Treatment
- Biomaterials, Available online 10 June 2021, 120967 | https://doi.org/10.1016/j.biomaterials.2021.120967
- 2021-06
- 의약학
- 한빛사논문
RNA-Binding Protein HuD Controls Insulin Translation
- Mol. Cell, 01 March 2012 | 10.1016/j.molcel.2012.01.016
- 2012-03
- 의약학
- 한빛사논문
- 김욱(National Institutes of Health, 현 아주대학교)
The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
- Pharmacol. Rev., December 2008 vol. 60 no. 4 470-512.
- 2008-12
- 의약학
- 한빛사논문, 상위피인용논문

연구자 ID

저자논문